COMBINATION OF AN ATP-COMPETITIVE INHIBITOR OF BCR/ABL KINASE ACTIVITY AND A TYRPHOSTIN ANALOG
摘要
<p>The present invention relates to a combination of (a) an ATP-competitive inhibitor of Bcr/abl kinase activity and (b) a tyrphostin analog, and the use of said combination or product for the treatment of bcr/abl-related diseases.</p>
